This cohort comprised 34 stage I (33.01%), 50 stage II (48.54%), and 19 stage III (18.45%) breast cancer patients, classified according to tumor, node, metastasis staging (TNM).[44] IHC staining results revealed that BCKDK and p‐RNF8S157 were weakly presented in adjacent normal tissues but highly abundant in cancer tissues (Figure 5b). The gene discussed is BCKDK; the disease is neoplasm.